Clinical forecasting is now leveraging innovative informatics capabilities for more precise recruitment and endpoint projections during a study’s crucial…


Facing thousands of Accutane claims, Roche wins appeal of $18M jury verdict

Roche cancer drugs continue to shine, but biosimilars are on the way

Lymphoma trial failure endangers Roche's Gazyva growth plans as Rituxan biosims loom

BioMarin rises again on buzz of a potential takeover--this time from Roche

Roche's MS med ocrelizumab hits FDA fast track, eyeing earlier-than-expected launch

Big Pharma harvests far more from transplants than homegrown meds

Cotellic is Roche's latest cancer med to hit a snag at NICE

Roche offloads Spanish production site to CMO Famar

India's Reliance Life Sciences brings first bevacizumab biosim to market

UPDATE: Genentech, OSI shell out $67M to settle cancer-drug marketing claims: DOJ